Working… Menu

An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris (APEX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04148287
Recruitment Status : Terminated (The trial was closed early as the result of the impact of COVID-19 on trial-related activities. The study was not terminated due to any safety issues or concerns. The objectives of the study were successfully met.)
First Posted : November 1, 2019
Last Update Posted : April 23, 2021
Information provided by (Responsible Party):
Amplyx Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 30, 2020
Actual Study Completion Date : December 31, 2020